CREFX | NBRIX | CREFX / NBRIX | |
Total Expense Ratio | 0.75 | 0.85 | 88% |
Annual Report Gross Expense Ratio | 0.75 | 1.03 | 73% |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 5.114 | -0.004 | -126,791% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 671M | 1,238% |
Annual Yield % from dividends | 2.55 | 2.23 | 114% |
Returns for 1 year | -3.49 | -7.02 | 50% |
Returns for 3 years | 29.60 | 9.31 | 318% |
Returns for 5 years | 37.37 | 13.89 | 269% |
Returns for 10 years | N/A | 20.25 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RWMGX | 66.86 | N/A | N/A |
American Funds Washington Mutual R6 | |||
JFNSX | 65.88 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
LICPX | 17.97 | N/A | N/A |
Lord Abbett International Equity P | |||
GISYX | 17.65 | N/A | N/A |
Grandeur Peak Intl Stalwarts Instl | |||
LVAVX | 15.00 | N/A | N/A |
LSV Conservative Value Equity Investor |